FDA calls on emerging plant to halt production during investigation into inflammatory Covid vaccines
The Emergent BioSolutions plant, a manufacturing partner for Johnson & Johnson’s Covid-19 vaccine, in Baltimore, Maryland, on April 9, 2021.Saul Loeb | AFP | Getty ImagesThe Food and Dru…
